Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis-Reference-Cited by-同舟云学术

Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis

Published:2013-06-07 Issue:11 Volume:26 Page:1492-1497
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Mason Emily F,Hornick Jason L

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201386.pdf

Reference43 articles.

1. Marrari A, Wagner AJ, Hornick JL . Predictors of response to targeted therapies for gastrointestinal stromal tumors. Arch Pathol Lab Med 2012;136:483–489.

2. Rubin BP, Heinrich MC, Corless CL . Gastrointestinal stromal tumour. Lancet 2007;369:1731–1741.

3. Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–480.

4. Demetri GD, van Oosterom AT, Garrett CR et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006;368:1329–1338.

5. Liegl-Atzwanger B, Fletcher JA, Fletcher CDM . Gastrointestinal stromal tumors. Virchows Arch 2010;456:111–127.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal tumours of the small intestine;Morson and Dawson's Gastrointestinal Pathology;2024-08-30

2. USP5 Promotes Ripretinib Resistance in Gastrointestinal Stromal Tumors by MDH2 Deubiquition;Advanced Science;2024-07-08

3. The Role of DNA Methylation in Gastrointestinal Disease: An Expanded Review of Malignant and Nonmalignant Gastrointestinal Diseases;Gastroenterology;2024-07

4. Molecular features of gastrointestinal stromal tumors “wild-type” (<i>KIT/PDGFRA</i> WT);Advances in Molecular Oncology;2023-12-15

5. Methylation and hydroxymethylation in cancer;Epigenetic Cancer Therapy;2023